Thomas DesRosier
Vermogen: 58 223 $ op 31-05-2026
Vermogen: 58 223 $ op 31-05-2026
Thomas J.
DesRosier is currently Director at Avanir Pharmaceuticals, Inc., Director at Optimer Pharmaceuticals LLC since 2013, and Chief Legal Officer & Executive Vice President at Seres Therapeutics, Inc. since 2016.
Former positions include Director at Trius Therapeutics, Inc.; Assistant General Counsel-Patents at Wyeth LLC; Chief Patent Counsel & Vice President at Genetics Institute LLC; Secretary, Chief Legal & Administrative Officer at ARIAD Pharmaceuticals, Inc. from 2015 to 2016; Secretary, Chief Legal & Administrative Officer at Cubist Pharmaceuticals LLC from 2013 to 2015; Chief Legal Officer, SVP & General Counsel at Genzyme Corp.
from 1999 to 2011; Senior Vice President & General Counsel at Sanofi from 2011 to 2013; and Principal roles at Wyeth Pharmaceuticals LLC, Lantheus Medical Imaging, Inc., and Dupont De Nemours & Co., Inc. Education includes undergraduate studies at the University of Vermont and graduate studies at Wake Forest University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 7.954 ( 0,08% ) | 58 223 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Algemeen Adviseur | 16-05-2016 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Directeur/Bestuurslid | 24-10-2013 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Hoofd Administratief Officier | 01-01-2016 |
| CUBIST PHARMACEUTICALS INC | Hoofd Administratief Officier | 22-01-2015 |
| SANOFI | Algemeen Adviseur | 01-01-2013 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Algemeen Adviseur | 01-01-2011 |
| AVANIR PHARMACEUTICALS INC | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 15 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Dupont De Nemours & Co., Inc.
Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Manufactures hybrid corn and soybean seeds | Process Industries |
Seres Therapeutics, Inc.
Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Wake Forest University School of Law
Wake Forest University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau